Cargando…
Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy
Neoadjuvant immunotherapy has the potential to enhance clinical outcomes by increasing anti-tumor immune responses in the presence of abundant tumor-derived antigen in an immune microenvironment that has not been exposed to previous therapy. The current mainstay of advanced head and neck squamous ce...
Autores principales: | Shibata, Hirofumi, Saito, Shin, Uppaluri, Ravindra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451593/ https://www.ncbi.nlm.nih.gov/pubmed/34552878 http://dx.doi.org/10.3389/fonc.2021.727433 |
Ejemplares similares
-
Epigenetic modulation of immunotherapy and implications in head and neck cancer
por: Zhou, Liye, et al.
Publicado: (2021) -
Neoadjuvant immunotherapy in breast cancer: a paradigm shift?
por: Fountzila, Elena, et al.
Publicado: (2020) -
Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021) -
Personalized cancer vaccination in head and neck cancer
por: Shibata, Hirofumi, et al.
Publicado: (2021) -
Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019)